JD Health International valuation

6618 · HKEX · HKD

Compare JD Health International
$32.60Change from previous close: +0.56%Absolute change: +$0.18

Close · November 20, 2026

Valuation

The P/E ratio is 15.0. The average price target of 16 analysts is $64.11.

Data as of November 22, 2026

JD Health International compared with similar companies

JD Health International's P/E (trailing 12 months): 15.0, −34% against the median of a group of 10 similar companies (22.8).

JD Health International's metrics compared with similar companies
MetricJD Health InternationalMedian25th–75th percentileBand
P/E (trailing 12 months)15.022.818.2 – 32.3Low
Forward P/E11.321.613.0 – 40.3Low
EV/EBITDA10.817.211.9 – 52.8Low
Price/book1.433.822.98 – 7.10Low
Price/sales1.321.320.81 – 2.85Middle
Gross margin25.3%27.1%22.7% – 44.5%Middle
Operating margin6.1%6.1%4.8% – 9.1%Middle
Net margin7.9%5.7%2.6% – 8.0%Middle
ROE10.4%19.7%10.9% – 20.7%Low
Debt/equity0.010.550.12 – 0.96Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same and related industries, similar size

Other metrics

Valuation multiples

Market cap
$103.98B
Enterprise value
$55.19B
PEG
2.18
EV/revenue
0.70

Profitability and growth

ROA
3.7%
ROIC
5.0%
Revenue growth (year over year)
15.9%
Earnings growth (year over year)
32.1%

Financial health

Total cash
$49.27B
Total debt
$874.85M
Current ratio
2.69
Quick ratio
2.33
Altman Z-Score
5.73
Piotroski F-Score
6.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$64.11
Median price target
$62.44
High price target
$96.18
Low price target
$44.88
Analysts with a price target
16
Consensus
Strong buy
Forward EPS
$2.90
EPS estimate, current year
$2.11

Shares and trading

Beta
1.22
Average volume
10.08M
Shares outstanding
3.19B
Float
1.01B
Institutional ownership
17.0%
Insider ownership
68.2%